RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Epidemiology of trachoma and its implications for implementing the “SAFE” strategy in Somali Region, Ethiopia
Results of 14 population-based prevalence surveys
Duale, A. B., Negussu Ayele, N., Macleod, C. K., Kello, A. B., Eshetu Gezachew, Z., Binegdie, A., Dejene, M., Alemayehu, W., Flueckiger, R. M., Massae, P. A., Willis, R., Kebede Negash, B., & Solomon, A. W. (2018). Epidemiology of trachoma and its implications for implementing the “SAFE” strategy in Somali Region, Ethiopia: Results of 14 population-based prevalence surveys. Ophthalmic Epidemiology, 25(sup1), 25-32. https://doi.org/10.1080/09286586.2017.1409358
Purpose: Ethiopia is highly trachoma endemic. Baseline mapping was needed in Ethiopia’s Somali Region to guide elimination efforts. Methods: Cross-sectional community-based surveys were conducted in 34 suspected trachoma-endemic woredas, grouped as 14 evaluation units (EUs), using a standardised mapping methodology developed for the Global Trachoma Mapping Project. Results: In total, 53,467 individuals were enumerated. A total of 48,058 (89.9%) were present at the time of survey teams’ visits and consented to examination. The prevalence of trachomatous inflammation–follicular (TF) among children aged 1–9 years ranged from 4.1% in the EU covering Danot, Boh, and Geladin woredas in Doolo Subzone to 38.1% in the EU covering Kebribeyah and Hareshen woredas in Fafan Subzone (East). The trichiasis prevalence among adults aged over 15 years varied from 0.1% in the EU covering Afder, Bare, and Dolobay woredas in Afder Subzone (West) to 1.2% in the EU covering Awbere in Fafan Subzone (West). Conclusion: Mass drug administration (MDA) with azithromycin is needed in 13 EUs (population 2,845,818). Two EUs (population 667,599) had TF prevalences in 1–9-year-olds of ≥30% and will require at least 5 years of MDA; 5 EUs (population 1,1193,032) had TF prevalences of 10–29.9% and need at least three years of MDA; 6 EUs (population 985,187) had TF prevalences of 5–9.9% and need at least one round of azithromycin distribution before re-survey. In all 13 of these EUs, implementation of facial cleanliness and environmental improvement measures is also needed. Surveys are still needed in the remaining 34 unmapped woredas of Somali Region.